Advertisement

Ads Placeholder
EU Stocks

ALCYB.PA €0.0004 on EURONEXT 11 Feb 2026: heavy volume flags active trading

February 11, 2026
6 min read
Share with:

Intraday the focus is on ALCYB.PA stock, trading at €0.0004 on EURONEXT on 11 Feb 2026. Volume is the headline: 689,090,701 shares have changed hands versus an average of 251,542,800, lifting relative volume to about 2.74x. That surge compares with a market cap near €4,503,400.00 and highlights highly active microcap trading. We examine what the volume means for short-term traders, the company’s financial footing, and plausible price targets in today’s intraday session.

Intraday snapshot and trading facts for ALCYB.PA stock

ALCYB.PA stock is trading at €0.0004 with a day range of €0.0003–€0.0005 and no net change on the last print. Volume stands at 689,090,701 against an average volume of 251,542,800, pushing relVolume to 2.74. Shares outstanding total 11,258,500,096, which explains how large share flows can move price quickly.

Advertisement

The stock trades on EURONEXT in Europe, uses EUR as currency, and sits in the Consumer Cyclical / Leisure sector. Day-to-day moves will be driven more by trade flows than fundamentals given the tiny quoted price and microcap market cap.

Why volume matters now for ALCYB.PA stock

High intraday volume suggests increased trading interest, not necessarily news. With a tiny free float and 11,258,500,096 shares outstanding, blocks or retail waves cause outsized swings. The 50-day average price is €0.000474 and the 200-day average is €0.000234, so today’s trade sits between those moving averages.

Active trading raises bid-ask spread risk. For short-term traders, volume can offer momentum, but thin liquidity can create rapid reversals. Institutional participation is unlikely at this level; expect retail-led patterns and sharp intraday volatility.

Financials, valuation and key ratios for ALCYB.PA stock

Cybergun S.A. reports trailing EPS of -0.15, a negative P/E, and a market cap of €4,503,400.00. Price-to-sales is 0.10, gross margin is 32.78%, and current ratio is about 1.02. Free cash flow per share is negative, reflecting constrained operational cash conversion.

These metrics show a distressed microcap. Debt-to-market-cap reads near 2.00x, enterprise value about €12,255,400.00, and interest coverage is deeply negative. That combination increases risk for investors focused on fundamentals, even with short-term trading opportunities.

Meyka AI rating and technical signals for ALCYB.PA stock

Meyka AI rates ALCYB.PA with a score out of 100: 58.70 — Grade C+, Suggestion: HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, analyst consensus, and forecast models. Grades are informational and not investment advice.

Technicals show a higher short-term momentum: relVolume 2.74x, price vs 50-day average slightly lower, and ADX is shown at 50 indicating a strong trend reading. Oscillators are limited on such low-priced securities, so we weigh volume and moving averages more than standard momentum indicators.

Risks and catalysts shaping ALCYB.PA stock

Key risks include low liquidity, negative EPS, and a volatile microcap profile. Corporate risks include licensing and supply-chain exposure tied to replica weapon brands. The next scheduled public earnings note in data shows an earnings announcement on 2025-11-04, but corporate updates or licensing deals would be primary catalysts here.

Positive catalysts could be licensing wins, a cut in operating cost, or acquisition interest. Any corporate news would likely cause outsized intraday moves given the small market cap and large float.

Price targets, short-term outlook and ALCYB.PA stock forecast

For intraday and short-term traders we set pragmatic price levels. A reasonable short-term target is €0.0020 if volume sustains, and a medium-term recovery target could be €0.0100 if fundamentals improve or a corporate catalyst appears. A stop-loss discipline is essential because a quick move below €0.0003 can accelerate declines.

Meyka AI’s forecast model projects a long-term value at €17.877347. Compared with the current €0.0004, that implies an extremely large percentage upside of about 4,469,150.00%. Forecasts are model-based projections and not guarantees. Treat that figure as a modeled scenario, not a likely near-term outcome. For more company details see Cybergun’s site source and the EURONEXT listing source.

Final Thoughts

ALCYB.PA stock trades as an active microcap on EURONEXT at €0.0004 on 11 Feb 2026, backed by a pronounced volume surge of 689,090,701 shares. That volume creates trading opportunities but also high execution risk. Financials show negative EPS of -0.15, a market cap of €4,503,400.00, and weak cash flow metrics. Meyka AI rates ALCYB.PA with a score out of 100 at 58.70 (Grade C+, Suggestion: HOLD), reflecting mixed signals between sector peers and fragile fundamentals. Short-term traders may aim for a tactical target near €0.0020 with tight risk controls. Our models include a long-term projection of €17.877347; this implies extreme upside versus the current quote, but it is a model outcome and not a forecast guarantee. Use tight stops, monitor news for licensing or corporate developments, and treat any intraday gains as speculative given liquidity constraints. Meyka AI provides this as data-driven market analysis and not investment advice.

Advertisement

FAQs

What is the current price and liquidity status of ALCYB.PA stock?

ALCYB.PA stock is trading at €0.0004 on EURONEXT with intraday volume at 689,090,701, about 2.74x the average. Liquidity is thin and price can move quickly on blocks or retail waves.

What does Meyka AI say about ALCYB.PA stock grade?

Meyka AI rates ALCYB.PA with a score out of 100 at 58.70, Grade C+, Suggestion: HOLD. This factors sector comparison, metrics, growth, forecasts, and consensus. Not financial advice.

Are there realistic price targets for ALCYB.PA stock?

Short-term target for active traders is €0.0020 with strict stops. A medium-term recovery target could be €0.0100 if corporate catalysts appear. All targets depend on liquidity and news.

How should traders manage risk with ALCYB.PA stock intraday?

Use tight stop-losses, avoid large size relative to average volume, and expect wide spreads. Monitor order book depth and corporate news closely before adding exposure.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

Advertisement

Ads Placeholder
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
~15% average open rate and growing
Trusted by 10,000+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)